Transcatheter Aortic Valve Replacement
Advanced treatment for patients with aortic stenosis
Carondelet Health Network is proud to offer the Transcatheter Aortic Valve Replacement (TAVR) program to residents in Tucson and Southern Arizona. Our TAVR surgery team is composed of a multidisciplinary, collaborative group of physicians and caregivers, including interventional cardiologists, cardiothoracic surgeons, imaging professionals, anesthesiologists, advanced care nurses and valve clinic coordinators.
Our cohesive approach embodies optimal patient-centric care and collaborative therapy decisions. If you have aortic stenosis, your physician will conduct a comprehensive evaluation to determine whether the TAVR procedure is appropriate and recommend a treatment plan.
What is aortic stenosis?
Aortic stenosis (AS) is one of the most common and serious valve diseases. With AS, the opening of the aortic heart valve narrows. As a result, the heart needs to work harder and may not pump enough oxygen-rich blood to the body. Aortic stenosis can be caused by a birth defect, rheumatic fever, radiation therapy or can be related to age.
Approximately 2.5 million people in the United States over the age of 75 suffer from this condition. In elderly individuals, aortic stenosis is sometimes caused by the buildup of calcium (mineral deposits) on the aortic valve’s leaflets. Over time, the leaflets become stiff, which reduces their ability to fully open and close. When the leaflets don’t fully open, a person’s heart must work harder to push blood through the aortic valve to the rest of the body. As a result, less oxygen-rich blood flows from the lungs to the brain and the rest of the body, which may cause symptoms.
Risks for aortic valve disease:
- Aging
- High blood pressure
- High cholesterol
- Smoking
What are the symptoms of aortic stenosis?
Symptoms may be misunderstood as a common sign of aging:
- Fainting
- Breathlessness
- Chest pain, pressure or tightness
- A decline in activity level or reduced ability to do routine physical tasks
Individuals may live with aortic stenosis for many years during a latent, asymptomatic period, even before the condition's symptoms develop. If experiencing these symptoms, please see a physician for a proper diagnosis.
Severe symptomatic AS can be life-threatening without treatment.
Individuals with severe AS may have a survival rate as low as 50% at two years and 20% at five years without getting treatment after symptoms appear. Traditional treatment for this condition is open-heart surgery, which can lead to extensive hospital stays and recovery times.
Transcatheter aortic valve replacement may be a safer option for patients with severe AS for whom open heart surgery is too high a risk.
Frequently asked questions about TAVR
A TAVR procedure may help your heart work better, extending the quality and length of life if you have serious aortic stenosis. It may also reduce your recovery time to get back to everyday tasks. Quality of life studies have shown improvements in patient health within 30 days, including the ability to take care of themselves and participate in routine tasks.
Patients will be evaluated for risks such as operative mortality, patient frailty, significant organ system compromise, other major comorbidities and procedure-specific impediments. Like most surgeries, though there is a low chance of having one, there are risks when a patient undergoes a TAVR process, such as heart attack, stroke, bleeding, need for emergency operation and potential damage to the electrical system of the heart.
Transcatheter aortic valve replacement is a less invasive, catheter-based technique for replacing the diseased aortic valve. An interventional cardiologist and a cardiothoracic surgeon will work together in the TAVR process. They will guide a new valve into the heart through an incision in the leg , using guidance from X-ray and echocardiography.
Multiple access approaches can be used to perform the TAVR process. However, the most frequent approach is the transfemoral approach, in which the valve is delivered via a catheter through the femoral artery. A less intrusive approach uses a small incision in the chest to enter the tip of the left ventricle; this is also called the transapical approach.